Office Depot, Inc. (NASDAQ: ODP), a leading global provider of office
products, services, and solutions formed by the merger of Office
Depot and OfficeMax, today announced it has been awarded two contracts,
valued in excess of $400 million, following a competitive solicitation
process for both office and school supplies by Region 4 Education
Service Center, the lead agency for The Cooperative Purchasing Network
(TCPN). TCPN offers cooperative contract solutions to K-12 schools,
local governments, colleges and universities.

Sonic Foundry, Inc. (NASDAQ: SOFO), the trusted leader for video
creation and management
solutions , believes video is the single most transformative asset
for a campus or the enterprise, and today presents its predictions for
the top video trends in 2015.

Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and
development-focused biotechnology company dedicated to creating small
molecule drugs primarily in the infectious disease field, today
announced the U.S. Food and Drug Administration (FDA) has approved
AbbVie’s VIEKIRA PAK™ (ombitasvir/paritaprevir/ritonavir tablets;
dasabuvir tablets) with or without ribavirin for the treatment of
genotype 1 (GT1) patients with chronic hepatitis C virus (HCV)
infection, including those with compensated cirrhosis.

Ferro Corporation (NYSE: FOE, “Company”) announced today that it has
completed the sale of the majority of the assets of its Polymer
Additives business to Polymer Additives, Inc., a wholly owned portfolio
company of H.I.G. Capital, LLC, for approximately $154 million in cash,
subject to customary working capital and other purchase price
adjustments.

By Victor Reklaitis, MarketWatch
'Simply no reason to buy Russia,' one strategist says
NEW YORK (MarketWatch) -- Russia's stocks performed badly, or uzhasno as Vladimir Putin might put it, while India's stocks registered a terrific 2014 thanks to "Modi mania" -- and each country's equity market easily could stay on its current track in 2015.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that
its partner Pfizer has received EU marketing authorization for DUAVIVE®
(conjugated estrogens/bazedoxifene (BZA/CE)) from the European
Commission.

By Juliet Chung, Gregory Zuckerman and David Benoit
Big investors suffer large losses as energy-related bets sour
The recent slide in oil prices has caused sharp losses among some of Wall Street's biggest names, the latest in a series of bad bets made by star investors during 2014.

Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's
X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web"
award winner for five years running, X-Ray Interpreter goes under the hood of
your portfolio to provide a useful allocation, sector, and geographic analysis.
And you can discover how much of a stock you really own, individually and
through mutual funds, with Stock Intersection.

Portfolio Monitor
Get a clear view of your investments with personalized reports about
your portfolio. Receive monthly statements and generate reports
on-demand to help you stay on track to meet your investment goals.